| Dr Ann M Lee, DO | |
|
1301 33rd St S, Saint Cloud, MN 56301-9668 | |
| (320) 251-8181 | |
| (320) 251-6942 |
| Full Name | Dr Ann M Lee |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 17 Years |
| Location | 1301 33rd St S, Saint Cloud, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164673190 | NPI | - | NPPES |
| 1164673190 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 51394 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centracare Health Home Care | Saint cloud, MN | Home health agency |
| St Cloud Hospital | Saint cloud, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centracare Clinic | 2466363395 | 632 |
| Novacare Outpatient Rehabilitation East Inc | 3678480290 | 617 |
| St Cloud Hospital | 4880594779 | 188 |
News Archive
Melatonin is known to have cancer-protective properties, and shift work can induce desynchrony of the circadian system, reducing melatonin production. Shift work has been thought to have important health impacts, with evidence linking shift work to an increased risk of several cancers including breast, endometrial, prostate, and colorectal, and non-Hodgkin lymphoma.
Kidz-Med Inc., a subsidiary of American Scientific Resources, Inc. (Pink Sheets: ASFX) is pleased to announce that the Kidz-Med Thermofocus 5-in-1 Non-Contact Thermometer and Pacifier Medicine Dispenser will be featured on Better TV airing live from 10-11am EST on CBS - TV channel 3 Connecticut Tuesday, September 29.
A single genetic test that is capable of detecting all mutations involved in the development of cystic fibrosis could be just a few years away, the 20th annual conference of the European Society of Human Reproduction and Embryology heard today (Monday 28 June).
Palatin Technologies, Inc. today announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for sexual dysfunction. The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old. The study will also evaluate consistency of plasma exposure of bremelanotide given as repeated subcutaneous injections.
Patients enter hospitals every day for a variety of reasons but usually without the thought of developing a new health problem. Yet every year thousands of hospitalized Americans acquire infections during hospital stays, causing risk of complications, prolonged stays and an increased burden on the health-care system.
› Verified 2 days ago
| Entity Name | Centracare Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043212665 PECOS PAC ID: 2466363395 Enrollment ID: O20031105000293 |
News Archive
Melatonin is known to have cancer-protective properties, and shift work can induce desynchrony of the circadian system, reducing melatonin production. Shift work has been thought to have important health impacts, with evidence linking shift work to an increased risk of several cancers including breast, endometrial, prostate, and colorectal, and non-Hodgkin lymphoma.
Kidz-Med Inc., a subsidiary of American Scientific Resources, Inc. (Pink Sheets: ASFX) is pleased to announce that the Kidz-Med Thermofocus 5-in-1 Non-Contact Thermometer and Pacifier Medicine Dispenser will be featured on Better TV airing live from 10-11am EST on CBS - TV channel 3 Connecticut Tuesday, September 29.
A single genetic test that is capable of detecting all mutations involved in the development of cystic fibrosis could be just a few years away, the 20th annual conference of the European Society of Human Reproduction and Embryology heard today (Monday 28 June).
Palatin Technologies, Inc. today announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for sexual dysfunction. The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old. The study will also evaluate consistency of plasma exposure of bremelanotide given as repeated subcutaneous injections.
Patients enter hospitals every day for a variety of reasons but usually without the thought of developing a new health problem. Yet every year thousands of hospitalized Americans acquire infections during hospital stays, causing risk of complications, prolonged stays and an increased burden on the health-care system.
› Verified 2 days ago
| Entity Name | St Cloud Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043269798 PECOS PAC ID: 4880594779 Enrollment ID: O20110221000134 |
News Archive
Melatonin is known to have cancer-protective properties, and shift work can induce desynchrony of the circadian system, reducing melatonin production. Shift work has been thought to have important health impacts, with evidence linking shift work to an increased risk of several cancers including breast, endometrial, prostate, and colorectal, and non-Hodgkin lymphoma.
Kidz-Med Inc., a subsidiary of American Scientific Resources, Inc. (Pink Sheets: ASFX) is pleased to announce that the Kidz-Med Thermofocus 5-in-1 Non-Contact Thermometer and Pacifier Medicine Dispenser will be featured on Better TV airing live from 10-11am EST on CBS - TV channel 3 Connecticut Tuesday, September 29.
A single genetic test that is capable of detecting all mutations involved in the development of cystic fibrosis could be just a few years away, the 20th annual conference of the European Society of Human Reproduction and Embryology heard today (Monday 28 June).
Palatin Technologies, Inc. today announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for sexual dysfunction. The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old. The study will also evaluate consistency of plasma exposure of bremelanotide given as repeated subcutaneous injections.
Patients enter hospitals every day for a variety of reasons but usually without the thought of developing a new health problem. Yet every year thousands of hospitalized Americans acquire infections during hospital stays, causing risk of complications, prolonged stays and an increased burden on the health-care system.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ann M Lee, DO 251 County Road 120, Saint Cloud, MN 56303-4872 Ph: (320) 251-8181 | Dr Ann M Lee, DO 1301 33rd St S, Saint Cloud, MN 56301-9668 Ph: (320) 251-8181 |
News Archive
Melatonin is known to have cancer-protective properties, and shift work can induce desynchrony of the circadian system, reducing melatonin production. Shift work has been thought to have important health impacts, with evidence linking shift work to an increased risk of several cancers including breast, endometrial, prostate, and colorectal, and non-Hodgkin lymphoma.
Kidz-Med Inc., a subsidiary of American Scientific Resources, Inc. (Pink Sheets: ASFX) is pleased to announce that the Kidz-Med Thermofocus 5-in-1 Non-Contact Thermometer and Pacifier Medicine Dispenser will be featured on Better TV airing live from 10-11am EST on CBS - TV channel 3 Connecticut Tuesday, September 29.
A single genetic test that is capable of detecting all mutations involved in the development of cystic fibrosis could be just a few years away, the 20th annual conference of the European Society of Human Reproduction and Embryology heard today (Monday 28 June).
Palatin Technologies, Inc. today announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for sexual dysfunction. The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old. The study will also evaluate consistency of plasma exposure of bremelanotide given as repeated subcutaneous injections.
Patients enter hospitals every day for a variety of reasons but usually without the thought of developing a new health problem. Yet every year thousands of hospitalized Americans acquire infections during hospital stays, causing risk of complications, prolonged stays and an increased burden on the health-care system.
› Verified 2 days ago
Steven Danielson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 251 County Rd 120, Saint Cloud, MN 56303 Phone: 320-202-8949 Fax: 320-202-0756 | |
Fariha Furqan Qureshi, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1555 Northway Dr Ste 200, Saint Cloud, MN 56303 Phone: 320-240-3157 | |
Dr. Crispin Rabara Domingo Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4801 Veterans Dr, Saint Cloud, MN 56303 Phone: 320-252-1670 Fax: 320-355-6359 | |
Dr. Bartley Brandon Mueller, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1301 33rd St S, Saint Cloud, MN 56301 Phone: 320-202-8949 Fax: 320-202-0756 | |
Ashley Marie Mackinac, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4801 Veterans Dr, Saint Cloud, MN 56303 Phone: 167-032-0252 | |
Steven Weno, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 251 County Road 120, Saint Cloud, MN 56303 Phone: 320-202-8949 Fax: 320-202-0756 | |
Jennifer Ann Tarpenning, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1555 Northway Dr Ste 200, Saint Cloud, MN 56303 Phone: 320-240-3157 |